CN Patent

CN104761604A — 尿嘧啶核苷酸类似物及其制备方法和应用

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2015-07-08 · 11y expired

What this patent protects

本发明涉及尿嘧啶核苷酸类似物及其制备方法和应用。具体而言，本发明提供了具有下式（I）化合物尿嘧啶核苷酸类似物、其立体异构体或其药学上可接受盐及其制备方法和应用。这些化合物是RNA依赖性RNA病毒复制的抑制剂，并且可用作HCV NS5B聚合酶的抑制剂、HCV复制的抑制剂以及用于治疗哺乳动物的丙型肝炎感染，具有广阔的应用前景，有望开发成新一代抗病毒药。

USPTO Abstract

本发明涉及尿嘧啶核苷酸类似物及其制备方法和应用。具体而言，本发明提供了具有下式（I）化合物尿嘧啶核苷酸类似物、其立体异构体或其药学上可接受盐及其制备方法和应用。这些化合物是RNA依赖性RNA病毒复制的抑制剂，并且可用作HCV NS5B聚合酶的抑制剂、HCV复制的抑制剂以及用于治疗哺乳动物的丙型肝炎感染，具有广阔的应用前景，有望开发成新一代抗病毒药。

Drugs covered by this patent

Patent Metadata

Patent number: CN104761604A
Jurisdiction: CN
Classification: —
Expires: 2015-07-08
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.